FemPulse GmbH

Founded

2018

Staff

3

Organization type

RDM medtech

Region

Vienna

Cluster

LISAvienna

The FemPulse System is designed to provide individualized, discrete electrical stimulation therapy (neuromodulation) for the treatment of women's Over Active Bladder (OAB), including symptoms of urinary urgency, frequency and urge incontinence. Electrical pulses are delivered via a vaginally insertable ring that can be easily controlled by the patient via remote control. These help regulate the nerve functions that affect bladder function to relieve symptoms of OAB.

R&D:The portable FemPulse System was developed to provide women with the most patient-friendly neuromodulation option that does not require invasive surgery at all. The primary focus of development was to increase treatment acceptance among the millions of untreated and inadequately treated women suffering from OAB.

Production:As European manufacturer, FemPulse owns respective IPs and concentrates onto design and MDR - conformity; given that, FemPulse will evaluate to shift adequate production alike assembling to EU-geographies.

Services:not yet

Sales/Distribution:not yet